Clinical Trials Browser

Withdrawn × atezolizumab × 90 days × Clear all

NCT06572722 2026-04-27

Perioperative Immunotherapy for NSCLC (ECTOP-1030)

Phase 2 Withdrawn

Lung Neoplasms

NCT06713798 2026-03-23

INDIGO

Phase 2 Withdrawn

Lung Neoplasms